{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T04:17:48Z","timestamp":1759033068698},"reference-count":10,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2018,6,9]],"date-time":"2018-06-09T00:00:00Z","timestamp":1528502400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2018,6,9]],"date-time":"2018-06-09T00:00:00Z","timestamp":1528502400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100000026","name":"U.S. Department of Health & Human Services | NIH | National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["DA28874","DA15214","DA33641"],"award-info":[{"award-number":["DA28874","DA15214","DA33641"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neuropsychopharmacol"],"published-print":{"date-parts":[[2018,11]]},"DOI":"10.1038\/s41386-018-0116-7","type":"journal-article","created":{"date-parts":[[2018,6,9]],"date-time":"2018-06-09T14:03:31Z","timestamp":1528553011000},"page":"2335-2336","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Harmony and heresy of an L-type calcium channel inhibitor: suppression of cocaine seeking via increased dopamine transmission in the nucleus accumbens"],"prefix":"10.1038","volume":"43","author":[{"given":"Sarah E.","family":"Swinford-Jackson","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R. Christopher","family":"Pierce","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,6,9]]},"reference":[{"key":"116_CR1","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1007\/s13311-017-0532-0","volume":"14","author":"ZD Kabir","year":"2017","unstructured":"Kabir ZD, Martinez-Rivera A, Rajadhyaksha AM. From gene to behavior: L-type calcium channel mechanisms underlying neuropsychiatric symptoms. Neurotherapeutics. 2017;14:588\u2013613.","journal-title":"Neurotherapeutics"},{"key":"116_CR2","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1016\/0091-3057(92)90363-K","volume":"41","author":"A Kuzmin","year":"1992","unstructured":"Kuzmin A, Zvartau E, Gessa GL, Martellotta MC, Fratta W. Calcium antagonists isradipine and nimodipine suppress cocaine and morphine intravenous self-administration in drug-naive mice. Pharmacol Biochem Behav. 1992;41:497\u2013500.","journal-title":"Pharmacol Biochem Behav"},{"key":"116_CR3","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1038\/nn2054","volume":"11","author":"SM Anderson","year":"2008","unstructured":"Anderson SM, Famous KR, Sadri-Vakili G, Kumaresan V, Schmidt HD, Bass CE, Terwilliger EF, Cha JH, Pierce RC. CaMKII: A biochemical bridge linking accumbens dopamine and glutamate systems in cocaine seeking. Nat Neurosci. 2008;11:344\u201353.","journal-title":"Nat Neurosci"},{"issue":"12","key":"116_CR4","doi-asserted-by":"publisher","first-page":"2361","DOI":"10.1038\/s41386-018-0080-2","volume":"43","author":"Nii A. Addy","year":"2018","unstructured":"Addy NA, Nunes EJ, Hughley SM, Small KM, Baracz SJ, Haight JL, Rajadhyaksha AM. The L-type calcium channel blocker, isradipine, attenuates cue-induced cocaine-seeking by enhancing dopaminergic activity in the ventral tegmental area to nucleus accumbens pathway. Neuropsychopharmacology 2018, \n                    https:\/\/doi.org\/10.1038\/s41386-018-0080-2\n                    \n                  , (e-pub ahead of print).","journal-title":"Neuropsychopharmacology"},{"key":"116_CR5","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1007\/7854_2009_27","volume":"3","author":"I Willuhn","year":"2010","unstructured":"Willuhn I, Wanat MJ, Clark JJ, Phillips PE. Dopamine signaling in the nucleus accumbens of animals self-administering drugs of abuse. Curr Top Behav Neurosci. 2010;3:29\u201371.","journal-title":"Curr Top Behav Neurosci"},{"key":"116_CR6","doi-asserted-by":"publisher","first-page":"6693","DOI":"10.1523\/JNEUROSCI.18-17-06693.1998","volume":"18","author":"A Bonci","year":"1998","unstructured":"Bonci A, Grillner P, Mercuri NB, Bernardi G. L-type calcium channels mediate a slow excitatory synaptic transmission in rat midbrain dopaminergic neurons. J Neurosci. 1998;18:6693\u2013703.","journal-title":"J Neurosci"},{"key":"116_CR7","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1152\/jn.00757.2013","volume":"112","author":"Y Liu","year":"2014","unstructured":"Liu Y, Harding M, Pittman A, Dore J, Striessnig J, Rajadhyaksha A, Chen X. Cav1.2 and Cav1.3 L-type calcium channels regulate dopaminergic firing activity in the mouse ventral tegmental area. J Neurophysiol. 2014;112:1119\u201330.","journal-title":"J Neurophysiol"},{"key":"116_CR8","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1038\/35084134","volume":"412","author":"JW Grimm","year":"2001","unstructured":"Grimm JW, Hope BT, Wise RA, Shaham Y. Neuroadaptation. Incubation cocaine craving withdrawal. Nature. 2001;412:141\u20132.","journal-title":"Nature"},{"key":"116_CR9","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1016\/j.tins.2011.06.001","volume":"34","author":"CL Pickens","year":"2011","unstructured":"Pickens CL, Airavaara M, Theberge F, Fanous S, Hope BT, Shaham Y. Neurobiology of the incubation of drug craving. Trends Neurosci. 2011;34:411\u201320.","journal-title":"Trends Neurosci"},{"key":"116_CR10","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1037\/1064-1297.13.4.319","volume":"13","author":"JD Roache","year":"2005","unstructured":"Roache JD, Johnson BA, Ait-Daoud N, Mauldin JB, Thornton JE, Wells LT, Murff WL. Effects of repeated-dose isradipine on the abuse liability of cocaine. Exp Clin Psychopharmacol. 2005;13:319\u201326.","journal-title":"Exp Clin Psychopharmacol"}],"container-title":["Neuropsychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/s41386-018-0116-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41386-018-0116-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41386-018-0116-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,20]],"date-time":"2023-05-20T21:03:26Z","timestamp":1684616606000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41386-018-0116-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,6,9]]},"references-count":10,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2018,11]]}},"alternative-id":["116"],"URL":"https:\/\/doi.org\/10.1038\/s41386-018-0116-7","relation":{},"ISSN":["0893-133X","1740-634X"],"issn-type":[{"value":"0893-133X","type":"print"},{"value":"1740-634X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,6,9]]},"assertion":[{"value":"23 May 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 May 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 June 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}